n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Carotid Artery Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collice, M; Fazio, F; Fieschi, C; Gerundini, P; Gilardi, MC; Lenzi, GL; Pozzilli, C | 1 |
| Boyko, OB; Edwards, MK; Glazier, MC; Kung, HF; Marquart, CL; Park, HM; Wellman, HN | 1 |
2 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Carotid Artery Diseases
| Article | Year |
|---|---|
Assessment of regional cerebral reperfusion with SPECT and 123I-HIPDM in patients with EC-IC bypass.
Topics: Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Revascularization; Cerebrovascular Circulation; Energy Metabolism; Humans; Iodobenzenes; Tomography, Emission-Computed | 1984 |
I-123 HIPDM SPECT imaging and cerebral angiography for EC-IC bypass evaluation.
Topics: Adult; Carotid Artery Diseases; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Circulation; Cerebrovascular Disorders; Encephalomalacia; Female; Humans; Iodobenzenes; Male; Middle Aged; Postoperative Care; Tomography, Emission-Computed | 1987 |